EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hippocampal Metabolomics Reveal the Mechanism of α-Conotoxin [S9K]TxID Attenuating Nicotine Addiction

Meiting Wang, Weifeng Xu, Huanbai Wang, Cheng Cui, Rongyan He, Xiaodan Li, Jinpeng Yu iD, J Michael McIntosh, Dongting Zhangsun, Sulan Luo iD

Marine Drugs · 2026

DOI: 10.3390/md24010043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, 2026. Verfasst von Meiting Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Special Biomedicine, School of Medicine, College of Life Science and Technology, Guangxi University, Nanning 530004, China. Hauptthemen laut MEDLINE: Conotoxins, Hippocampus, Tobacco Use Disorder, Nicotinic Antagonists. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sulan Luo, Dongting Zhangsun, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nicotine is the main substance responsible for the development of tobacco addiction. The α3β4 nicotinic acetylcholine receptors (nAChRs) are a potential key target for mitigating nicotine reward. Preliminary studies in our laboratory suggest that α-conotoxin [S9K]TxID serves as a selective and potent antagonist targeting α3β4 nAChRs, which may be beneficial in addressing nicotine addiction. However, the mechanisms of [S9K]TxID treatment in nicotine addiction are still to be determined. This study aimed to identify the differential metabolic profiles of [S9K]TxID treatment in nicotine addiction using an untargeted metabolomic profiling method. As demonstrated by behavioral experiments, [S9K]TxID effectively attenuated nicotine-induced conditioned place preference (CPP) expression without exerting inhibitory effects on the central nervous system (CNS). The results of untargeted metabolomics revealed that eight metabolites were significantly altered after [S9K]TxID treatment, particularly phenylalanine. [S9K]TxID also attenuated nicotine-induced metabolic disorders by regulating phenylalanine, tyrosine and tryptophan biosynthesis. In conclusion, our findings suggest that [S9K]TxID could be a potential therapeutic compound for nicotine addiction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ConotoxinsHippocampusTobacco Use DisorderNicotinic AntagonistsAnimalsMetabolomicsReceptors, NicotinicNicotineMaleRatsRats, Sprague-Dawley

Stichwörter der Autor:innen

CPPmetabolomicsnicotine addictionα-conotoxin [S9K]TxIDα3β4 nAChRs

Substanzen

ConotoxinsReceptors, NicotinicNicotineNicotinic Antagonistsnicotinic receptor alpha3beta4

Autor:innen und Institutionen

  • Guangxi Key Laboratory of Special Biomedicine, School of Medicine, College of Life Science and Technology, Guangxi University, Nanning 530004, China.
  • Key Laboratory of Tropical Biological Resources of Ministry of Education, Hainan University, Haikou 570228, China.
  • Departments of Biology and Psychiatry, University of Utah, Salt Lake City, UT 84112, USA.
  • George E. Wahlen Veterans Affairs Medical Center, Salt Lake City, UT 84108, USA.

ORCID-Profile: Jinpeng Yu, Sulan Luo

Förderung

  • Sulan Luo
  • Dongting Zhangsun
  • NIGMS NIH HHS
  • Major International Joint Research Project of National Natural Science Foundation of China
  • Key Project of Natural Science Foundation of Guangxi
  • National Natural Science Foundation of China
  • “Dai Tu Yi Zhi” Project of Key R & D Program of Guangxi
  • Major Intergovernmental Joint Research Project of National Key R & D Program of China

Zitieren

APA

Wang, M., Xu, W., Wang, H., Cui, C., He, R., Li, X., Yu, J., McIntosh, J. M., Zhangsun, D., & Luo, S. (2026). Hippocampal Metabolomics Reveal the Mechanism of α-Conotoxin [S9K]TxID Attenuating Nicotine Addiction. Marine Drugs. https://doi.org/10.3390/md24010043

Vancouver

Wang M, Xu W, Wang H, Cui C, He R, Li X, et al. Hippocampal Metabolomics Reveal the Mechanism of α-Conotoxin [S9K]TxID Attenuating Nicotine Addiction. Marine Drugs. 2026. doi:10.3390/md24010043

BibTeX
@article{Wang2026,
  author = {Wang, Meiting and Xu, Weifeng and Wang, Huanbai and Cui, Cheng and He, Rongyan and Li, Xiaodan and Yu, Jinpeng and McIntosh, J Michael and Zhangsun, Dongting and Luo, Sulan},
  title = {Hippocampal Metabolomics Reveal the Mechanism of α-Conotoxin [S9K]TxID Attenuating Nicotine Addiction},
  journal = {Marine Drugs},
  year = {2026},
  doi = {10.3390/md24010043}
}
Kostenlos starten →